Novartis Investigative Site

Matsusaka, Mie-ken 515-8544

0 studies enrolling now · 2 studies all time

What they study most

Asthma, Pulmonary Disease, Chronic Obstructive

Studies at this site

• Dose-range Finding Efficacy and Safety Study for QBW251 in COPD Patients — Completed
• Study of Safety of QAW039 in Patients With Asthma Inadequately Controlled on Standard-of-care Asthma Treatment — Stopped early